1
|
Murakami K, Sasano Y, Tomizawa M, Shibuya M, Kwon E, Iwabuchi Y. Highly Enantioselective Organocatalytic Oxidative Kinetic Resolution of Secondary Alcohols Using Chiral Alkoxyamines as Precatalysts: Catalyst Structure, Active Species, and Substrate Scope. J Am Chem Soc 2014; 136:17591-600. [DOI: 10.1021/ja509766f] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Affiliation(s)
- Keiichi Murakami
- Department of Organic Chemistry,
Graduate School of Pharmaceutical
Sciences and ‡Research and Analytical Center for Giant Molecules, Graduate School
of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan
| | - Yusuke Sasano
- Department of Organic Chemistry,
Graduate School of Pharmaceutical
Sciences and ‡Research and Analytical Center for Giant Molecules, Graduate School
of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan
| | - Masaki Tomizawa
- Department of Organic Chemistry,
Graduate School of Pharmaceutical
Sciences and ‡Research and Analytical Center for Giant Molecules, Graduate School
of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan
| | - Masatoshi Shibuya
- Department of Organic Chemistry,
Graduate School of Pharmaceutical
Sciences and ‡Research and Analytical Center for Giant Molecules, Graduate School
of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan
| | - Eunsang Kwon
- Department of Organic Chemistry,
Graduate School of Pharmaceutical
Sciences and ‡Research and Analytical Center for Giant Molecules, Graduate School
of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan
| | - Yoshiharu Iwabuchi
- Department of Organic Chemistry,
Graduate School of Pharmaceutical
Sciences and ‡Research and Analytical Center for Giant Molecules, Graduate School
of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan
| |
Collapse
|
2
|
Hanessian S, Chénard E, Guesné S, Cusson JP. Conception and Evolution of Stereocontrolled Strategies toward Functionalized 8-Aryloctanoic Acids Related to the Total Synthesis of Aliskiren. J Org Chem 2014; 79:9531-45. [DOI: 10.1021/jo5015195] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- Stephen Hanessian
- Department of Chemistry, Université de Montréal, CP6128 Succursale A, Centre-ville, Montréal, Quebec H3C 3J7, Canada
| | - Etienne Chénard
- Department of Chemistry, Université de Montréal, CP6128 Succursale A, Centre-ville, Montréal, Quebec H3C 3J7, Canada
| | - Sébastien Guesné
- Department of Chemistry, Université de Montréal, CP6128 Succursale A, Centre-ville, Montréal, Quebec H3C 3J7, Canada
| | - Jean-Philippe Cusson
- Department of Chemistry, Université de Montréal, CP6128 Succursale A, Centre-ville, Montréal, Quebec H3C 3J7, Canada
| |
Collapse
|
3
|
Yokokawa F. Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension. Expert Opin Drug Discov 2013; 8:673-90. [DOI: 10.1517/17460441.2013.791279] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
4
|
Lorthiois E, Breitenstein W, Cumin F, Ehrhardt C, Francotte E, Jacoby E, Ostermann N, Sellner H, Kosaka T, Webb RL, Rigel DF, Hassiepen U, Richert P, Wagner T, Maibaum J. The discovery of novel potent trans-3,4-disubstituted pyrrolidine inhibitors of the human aspartic protease renin from in silico three-dimensional (3D) pharmacophore searches. J Med Chem 2013; 56:2207-17. [PMID: 23425156 DOI: 10.1021/jm3017078] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The small-molecule trans-3,4-disubstituted pyrrolidine 6 was identified from in silico three-dimensional (3D) pharmacophore searches based on known X-ray structures of renin-inhibitor complexes and demonstrated to be a weakly active inhibitor of the human enzyme. The unexpected binding mode of the more potent enantiomer (3S,4S)-6a in an extended conformation spanning the nonprime and S1' pockets of the recombinant human (rh)-renin active site was elucidated by X-ray crystallography. Initial structure-activity relationship work focused on modifications of the hydrophobic diphenylamine portion positioned in S1 and extending toward the S2 pocket. Replacement with an optimized P3-P1 pharmacophore interacting to the nonsubstrate S3(sp) cavity eventually resulted in significantly improved in vitro potency and selectivity. The prototype analogue (3S,4S)-12a of this new class of direct renin inhibitors exerted blood pressure lowering effects in a hypertensive double-transgenic rat model after oral administration.
Collapse
Affiliation(s)
- Edwige Lorthiois
- Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Požgan F, Štefane B, Kiđemet D, Smodiš J, Zupet R. The synthesis of 12-membered macrocycles containing a C1–C8 alkene unit via ring-closing metathesis. Tetrahedron 2012. [DOI: 10.1016/j.tet.2012.04.043] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
6
|
Campeau LC, Dolman SJ, Gauvreau D, Corley E, Liu J, Guidry EN, Ouellet SG, Steinhuebel D, Weisel M, O’Shea PD. Convergent Kilo-Scale Synthesis of a Potent Renin Inhibitor for the Treatment of Hypertension. Org Process Res Dev 2011. [DOI: 10.1021/op2001063] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Louis-Charles Campeau
- Global Process Chemistry, Merck-Frosst, 16711 Trans Canada Highway, Kirkland, Québec H9H 3L1, Canada
| | - Sarah J. Dolman
- Global Process Chemistry, Merck-Frosst, 16711 Trans Canada Highway, Kirkland, Québec H9H 3L1, Canada
| | - Danny Gauvreau
- Global Process Chemistry, Merck-Frosst, 16711 Trans Canada Highway, Kirkland, Québec H9H 3L1, Canada
| | - Ed Corley
- Global Process Chemistry, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Jinchu Liu
- Global Process Chemistry, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Erin N. Guidry
- Global Process Chemistry, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Stéphane G. Ouellet
- Global Process Chemistry, Merck-Frosst, 16711 Trans Canada Highway, Kirkland, Québec H9H 3L1, Canada
| | - Dietrich Steinhuebel
- Global Process Chemistry, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Mark Weisel
- Global Process Chemistry, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Paul D. O’Shea
- Global Process Chemistry, Merck-Frosst, 16711 Trans Canada Highway, Kirkland, Québec H9H 3L1, Canada
| |
Collapse
|
7
|
Lee YK, Player MR. Developments in factor Xa inhibitors for the treatment of thromboembolic disorders. Med Res Rev 2011; 31:202-83. [DOI: 10.1002/med.20183] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
8
|
Molinaro C, Shultz S, Roy A, Lau S, Trinh T, Angelaud R, O’Shea PD, Abele S, Cameron M, Corley E, Funel JA, Steinhuebel D, Weisel M, Krska S. A Practical Synthesis of Renin Inhibitor MK-1597 (ACT-178882) via Catalytic Enantioselective Hydrogenation and Epimerization of Piperidine Intermediate. J Org Chem 2011; 76:1062-71. [DOI: 10.1021/jo102070e] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Carmela Molinaro
- Department of Process Research, Merck, 16711 Autoroute Transcanadienne, Kirkland, Québec, Canada H9H 3L1
| | - Scott Shultz
- Department of Process Research, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Amélie Roy
- Department of Process Research, Merck, 16711 Autoroute Transcanadienne, Kirkland, Québec, Canada H9H 3L1
| | - Stephen Lau
- Department of Process Research, Merck, 16711 Autoroute Transcanadienne, Kirkland, Québec, Canada H9H 3L1
| | - Thao Trinh
- Department of Process Research, Merck, 16711 Autoroute Transcanadienne, Kirkland, Québec, Canada H9H 3L1
| | - Rémy Angelaud
- Department of Process Research, Merck, 16711 Autoroute Transcanadienne, Kirkland, Québec, Canada H9H 3L1
| | - Paul D. O’Shea
- Department of Process Research, Merck, 16711 Autoroute Transcanadienne, Kirkland, Québec, Canada H9H 3L1
| | - Stefan Abele
- Department of Process Research Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil, Switzerland
| | - Mark Cameron
- Department of Process Research, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Ed Corley
- Department of Process Research, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Jacques-Alexis Funel
- Department of Process Research Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil, Switzerland
| | - Dietrich Steinhuebel
- Department of Process Research, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Mark Weisel
- Department of Process Research, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| | - Shane Krska
- Department of Process Research, Merck, P.O. Box 2000, Rahway, New Jersey 07065, United States
| |
Collapse
|
9
|
Belen’kii L, Gramenitskaya V, Evdokimenkova Y. The Literature of Heterocyclic Chemistry, Part X, 2005–2007. ADVANCES IN HETEROCYCLIC CHEMISTRY 2011. [DOI: 10.1016/b978-0-12-385464-3.00001-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
10
|
Webb RL, Schiering N, Sedrani R, Maibaum J. Direct Renin Inhibitors as a New Therapy for Hypertension. J Med Chem 2010; 53:7490-520. [DOI: 10.1021/jm901885s] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Randy L. Webb
- Novartis Pharmaceuticals Corp., Institutes for BioMedical Research, East Hanover, New Jersey
| | - Nikolaus Schiering
- Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland
| | - Richard Sedrani
- Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland
| | - Jürgen Maibaum
- Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland
| |
Collapse
|
11
|
Hanessian S, Guesné S, Chénard E. Total synthesis of "aliskiren": the first Renin inhibitor in clinical practice for hypertension. Org Lett 2010; 12:1816-9. [PMID: 20235519 DOI: 10.1021/ol100427v] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We report a "macrocycle route" toward aliskiren, a drug presently marketed for the treatment of hypertension, using a highly stereocontrolled approach starting from a common "isopropyl chiron". Highlights of the synthesis include a challenging RCM reaction to produce a nine-membered unsaturated lactone, a highly stereoselective catalytic Du Bois aziridination, and a regio- and diastereoselective aziridine ring-opening to a vicinal amino alcohol.
Collapse
Affiliation(s)
- Stephen Hanessian
- Department of Chemistry, Universite de Montreal, C.P. 6128, Succ. Centre-Ville, Montreal, Quebec H3C 3J7, Canada.
| | | | | |
Collapse
|
12
|
Yokokawa F, Maibaum J. Recent advances in the discovery of non-peptidic direct renin inhibitors as antihypertensives: new patent applications in years 2000 – 2008. Expert Opin Ther Pat 2008. [DOI: 10.1517/13543776.18.6.581] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|